Related Experiment Video
Updated: Apr 15, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure
Sherin I Hashem1, Cynthia N Perry1, Matthieu Bauer1
1Division of Cardiology, Department of Medicine.
Abstract:
Danon disease is a familial cardiomyopathy associated with impaired autophagy due to mutations in the gene encoding lysosomal-associated membrane protein type 2 (LAMP-2). Emerging evidence has highlighted the importance of autophagy in regulating cardiomyocyte bioenergetics, function, and survival. However, the mechanisms responsible for cellular dysfunction and death in cardiomyocytes with impaired autophagic flux remain unclear. To investigate the molecular mechanisms responsible for Danon disease, we created induced pluripotent stem cells (iPSCs) from two patients with different LAMP-2 mutations. Danon iPSC-derived cardiomyocytes (iPSC-CMs) exhibited impaired autophagic flux and key features of heart failure such as increased cell size, increased expression of natriuretic peptides, and abnormal calcium handling compared to control iPSC-CMs. Additionally, Danon iPSC-CMs demonstrated excessive amounts of mitochondrial oxidative stress and apoptosis. Using the sulfhydryl antioxidant N-acetylcysteine to scavenge free radicals resulted in a significant reduction in apoptotic cell death in Danon iPSC-CMs. In summary, we have modeled Danon disease using human iPSC-CMs from patients with mutations in LAMP-2, allowing us to gain mechanistic insight into the pathogenesis of this disease. We demonstrate that LAMP-2 deficiency leads to an impairment in autophagic flux, which results in excessive oxidative stress, and subsequent cardiomyocyte apoptosis. Scavenging excessive free radicals with antioxidants may be beneficial for patients with Danon disease. In vivo studies will be necessary to validate this new treatment strategy.
Insights
Danon disease, caused by LAMP-2 mutations, impairs cardiomyocyte autophagy leading to heart failure. Antioxidant treatment reduced cell death, suggesting a potential therapy for this genetic cardiomyopathy.
Area of Science:
- Cardiology
- Genetics
- Cell Biology
Background:
- Danon disease is a genetic cardiomyopathy linked to impaired autophagy from mutations in lysosomal-associated membrane protein 2 (LAMP-2).
- Autophagy is crucial for cardiomyocyte health, but its role in Danon disease pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cellular dysfunction and death in Danon disease cardiomyocytes.
- To model Danon disease using patient-derived induced pluripotent stem cells (iPSCs).
Main Methods:
- Generated iPSC-derived cardiomyocytes (iPSC-CMs) from two Danon disease patients with distinct LAMP-2 mutations.
- Assessed autophagic flux, cardiomyocyte structure, calcium handling, oxidative stress, and apoptosis in Danon iPSC-CMs.
- Evaluated the therapeutic potential of the antioxidant N-acetylcysteine.
Main Results:
- Danon iPSC-CMs displayed impaired autophagic flux, hypertrophy, abnormal calcium handling, and increased apoptosis.
- Mitochondrial oxidative stress was significantly elevated in Danon iPSC-CMs.
- N-acetylcysteine treatment reduced apoptosis in Danon iPSC-CMs, indicating a role for free radical scavenging.
Conclusions:
- LAMP-2 deficiency impairs autophagic flux, leading to oxidative stress and cardiomyocyte apoptosis in Danon disease.
- Human iPSC-CMs provide a valuable model for studying Danon disease mechanisms.
- Antioxidant therapy targeting free radicals shows promise for treating Danon disease, warranting further in vivo investigation.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Coronary Artery Disease I: Introduction

